Select Medical Holdings Corporation announced that its stockholders approved the acquisition by a consortium led by Executive Chairman Robert A. Ortenzio, Senior Executive Vice President Martin F. Jackson, and Welsh, Carson, Anderson & Stowe at a special meeting on June 26, 2026. Approximately 82.54% of outstanding shares were voted, with over 79.88% of all outstanding shares and over 76.64% of shares held by unaffiliated stockholders voting in favor. The closing of the merger remains subject to the terms of the merger agreement and is expected to occur in mid-2026. Select Medical will file the final voting results with the SEC.
Select Medical HoldingsStockholders approved the acquisition by a consortium led by insiders and WCAS, a positive capital event for shareholders.